| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.004 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |